Cellectar biosciences to host key opinion leader event to review the full results from its clover wam pivotal trial and waldenstrom's macroglobulinemia market landscape

Florham park, n.j., june 27, 2024 (globe newswire) -- cellectar biosciences, inc. (nasdaq: clrb), a late-stage clinical biopharmaceutical company focused on the discovery, development and commercialization of drugs for the treatment of cancer, today announced it will host an event on july 24, 2024, at 8:00 a.m.
CLRB Ratings Summary
CLRB Quant Ranking